Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system. Findings highlighted the advanced hybrid closed-loop automated insulin delivery system’s benefits compared to the standard of care using multiple daily injections (MDI) with intermittently scanned continuous glucose monitoring (isCGM). MiniMed 780G, Medtronic’s latest-generation automated insulin delivery system, provides real-time […]
Medtronic
Medtronic has a new head of investor relations, former head to join Diabetes spin-off MiniMed
![Medtronic named Ingrid Goldberg (right) as its new head of investor relations. Ryan Weispfenning (left) will leave to lead investor relations for MiniMed. [Images from LinkedIn]](https://www.drugdeliverybusiness.com/wp-content/uploads/2025/12/Medtronic-VP-Head-of-investor-relations-Ryan-Weispfenning-MiniMed-Ingrid-Goldberg-150x86.jpg)
Medtronic (NYSE: MDT) announced today that it named Ingrid Goldberg as its new VP and head of investor relations (IR). Goldberg’s appointment comes as Ryan Weispfenning, who previously held that role, elected to join the company’s Diabetes business and lead the IR function for the unit as it continues to work toward a separation from […]
Medtronic begins full commercial rollout of MiniMed 780G with Instinct sensor made by Abbott
Medtronic (NYSE:MDT) today announced the full U.S. launch for its Instinct sensor, made by Abbott, paired with the MiniMed 780G pump. The medtech giant’s diabetes unit — one of the largest diabetes tech businesses in the world — won FDA clearance for its SmartGuard algorithm as an interoperable automated glycemic controller (iAGC) earlier this year, enabling […]
Medtronic Diabetes to submit patch pump to FDA by fall 2026, separation remains on track
Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO Thierry Piéton outlined the expected timelines for the Diabetes business, following another quarter of significant growth. Global Diabetes revenues grew 10.3% year over year, despite a […]
What diabetes tech companies are doing on World Diabetes Day 2025
Once again, World Diabetes Day, celebrated on Nov. 14 every year, has come around, highlighting new initiatives in the diabetes tech space. The date marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. It also lands during the American Diabetes Association’s National Diabetes Awareness Month. […]
The top CGM stories of 2025
Millions of people worldwide are looking for ways to manage their diabetes. That’s where the continuous glucose monitor (CGM) comes in. The CGM market is expected to experience substantial, double-digit percentage growth over the next five years, reaching nearly $29 billion by 2030. Market leaders Abbott and Dexcom continue to establish their hold on the […]
Billie Jean King supports Medtronic Diabetes awareness initiative
The annual Medtronic (NYSE:MDT) diabetes awareness initiative this year has the backing of sporting legend Billie Jean King. King, a former world No. 1 tennis player and pioneer in women’s sports, is participating in the company’s Blue Balloon Challenge this year. Introduced in 2021, the movement encourages people with diabetes to help drive awareness and […]
12 things you need to know about the CGM market
The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice — draws on numerous sources, including but not limited to: medical associations, government data, medical journals, leading medtech publications, clinical […]
CGM market report: Significant growth is ahead
As millions of people worldwide seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow rapidly. Medtech market analysts project significant growth for the market over the next five years. Chrystal Larsen, a veteran medtech market analyst, produced a detailed report for MassDevice outlining the future of the CGM market. The report covers […]
Court sides with Medtronic in insulin pump class action suit
A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge for the District of Minnesota, granted Medtronic’s motion to dismiss the suit initially brought forward by investors in 2022. Provinzino’s dismissal comes about a year-and-a-half after Katherine M. Menendez, […]
